Release Date: 13/03/18 20:22 Summary: Half Yearly Report and Accounts Price Sensitive: No Download Document 1010.52KB Download
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%